T

Telesis Bio

D
TBIO
USD
1.57
(115.4412%)
Market Closed
1,431,749.00
Volume
-2.37
EPS
-
Div Yield
-0.094346
P/E
5,194,731.78
Market Cap
Today
115.4412%
1 Week
61.878%
1 Month
-17.697%
6 Months
-68.454%
12 Months
-87.183%
Year To Date
-57.786%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
E
EDIT
0.05
(1.292%)
USD
C
CRSP
-0.11
(-0.2219%)
USD
B
BEAM
0.55
(2.1552%)
USD
N
NTLA
0.41
(1.8214%)
USD
S
SGMO
0.0617
(7.3584%)
USD
V
VCEL
1.62
(3.4921%)
USD
B
BLUE
-0.0046
(-0.9287%)
USD
C
CLLS
0.04
(1.7544%)
USD
R
RARE
1.17
(2.0316%)
USD

Title:
Telesis Bio Inc.

Sector:
Healthcare
Industry:
Medical Devices
Telesis Bio Inc is a synthetic biology company focused on enabling researchers to rapidly, accurately, and reproducibly build or write high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology-enabled markets. It manufactures and sells laboratory equipment, specifically synthetic biology instruments, reagents, and associated products and related services. Its products comprise of BioXp system, BioXp kits, Benchtop reagents and BioXp biofoundry services.
Do you need help or have a question?
Contact Us